Abstract:Objective To analyze the relationship between body mass index, lipid profile and non-alcoholic fatty liver disease (NAFLD). Methods A population-based, cross-sectional study was carried out in 10000 clients of health examination in the population of Hefei area in 2012. Body mass index (BMI), history of alcohol intake and past medical history were recorded. Subjects were divided into four groups according to the levels of BMI, clinical indicators included serum lipids, and fasting blood glucose and the rate of non-alcoholic fatty liver disease were compared among the four groups. Distribution of BMI of the masses in Hefei region was analyzed. The relationships between BMI and the incidences of hyperlipidemia and non-alcoholic fatty liver disease were discussed. Results (1)The occurring rate of obesity and overweight was 60%, normal weight was38.3%. (2)The incidence of overweight and obesity was distinct in different age groups (χ2=161.733,P=0.000).(3)Except for high density lipoprotein-cholesterol, indicators included triglyceride, total cholesterol, low density lipoprotein-cholesterol, fasting blood sugar and uric acid levels in overweight and obesity groups were significantly higher than those in normal group. (4)With the increasing of BMI, the incidence of non-alcoholic fatty liver disease and hyperlipidemia were increased. (5)Factors including BMI, gender (male), triglyceride, total cholesterol were independent risk for non-alcoholic fatty liver disease, whereas high density lipoprotein cholesterol was a protective factor. (6)ROC analysis demonstrated that the best cut off value of BMI in predicting the incidence of non-alcoholic fatty liver disease was 24.85 or 24.95 in male and 24.95 in female.ConclusionsOverweight and obesity are the risk factors for the prevalence of NAFLD and hyperlipidemia. Management of weight and targeted interventions rectifying the metabolism disorders at the earliest opportunity, which may contribute to reduce the risk of hyperlipidemia and NAFLD.
[1]Popkin BM. Does global obesity represent a global public health challenge?[J] Am J Clin Nutr,2011,93(2):232-233. [2]Day K, Alfonzo M, Chen Y, et al. Overweight, obesity, and inactivity and urban design in rapidly growing Chinese cities[J]. Health Place,2013,21C: 29-38. [3]Park JS, Seo JH, Youn HS. Gut Microbiota and clinical disease:obesity and nonalcoholic fatty liver disease. Pediatr Gastroenterol Hepatol Nutr[J]. 2013,16(1):22-27. [4]中国成人血脂异常防治指南制订联合委员会.中国成人血脂异常防治指南[J].中华心血管病杂志.2007, 35(5):390-419. [5]中华医学会肝病学分会脂肪肝和酒精性肝病学组.非酒精性脂肪性肝病诊疗指南(2010年修订版)[J].中华肝脏病杂志,2010,18(3):163-166. [6]Gorman A, Kaye EK, Apovian C,et al. Overweight and obesity predict time to periodontal disease progression in men[J]. J Clin Periodontol,2012,39(2):107-114. [7]Cai L, He J, Song Y,et al.Association of obesity with socio-economic factors and obesity-related chronic diseases in rural southwest China[J]. Public Health,2013,127(3):247-251. [8]Hsu CS, Kao JH.Non-alcoholic fatty liver disease: an emerging liver disease in Taiwan[J].J Formos Med Assoc,2012,111(10):527-535. [9]Vanni E, Bugianesi E, Kotronen A,et al.From the metabolic syndrome to NAFLD or vice versa[J]? Dig Liver Dis. 2010,42(5):320-330. [10]Dmaso AR, do Prado WL, de Piano A,et al. Relationship between nonalcoholic fatty liver disease prevalence and visceral fat in obese adolescents[J]. Dig Liver Dis,2008,40(2):132-139.